SODIUM NITROPRUSSIDE (sodium nitroprusside) by Baxter is clinical pharmacology the principal pharmacological action of sodium nitroprusside is relaxation of vascular smooth muscle and consequent dilatation of peripheral arteries and veins. Approved for acute congestive heart failure. First approved in 1982.
Drug data last refreshed 9h ago · AI intelligence enriched 2w ago
Sodium nitroprusside is a direct-acting vasodilator administered intravenously that relaxes vascular smooth muscle in both arteries and veins. It is indicated for acute congestive heart failure and hypertensive crisis, working by reducing preload and afterload through rapid peripheral vasodilation. The drug has a 2-minute circulatory half-life and produces hemodynamic effects within 1–2 minutes of infusion initiation.
Product approaching loss of exclusivity with modest competitive pressure (30%), indicating potential team consolidation and shift toward lifecycle extension or generic defense strategies.
CLINICAL PHARMACOLOGY The principal pharmacological action of sodium nitroprusside is relaxation of vascular smooth muscle and consequent dilatation of peripheral arteries and veins. Other smooth muscle (e.g., uterus, duodenum) is not affected. Sodium nitroprusside is more active on veins than on…
Worked on SODIUM NITROPRUSSIDE at Baxter? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on sodium nitroprusside offers limited career growth due to its mature, LOE-approaching status and absence of pipeline expansion; roles focus on operational efficiency, competitive defense, and customer relationship management rather than innovation or market development. This position suits professionals seeking stability in a niche acute-care market or those building expertise in generic/legacy product stewardship.